- Diagnostics
- Friday, 12 Jun 2020
Raxia Launches Contactless COVID-19 Screening and Patient Check-In Solution
Raxia recently surveyed medical practices regarding their COVID-19 screening processes for in-person doctor appointments. The survey, to be published June 22nd, was conducted via email and polled hundreds of doctors, nurses, and medical staff nationwide. While the surveyed practices universally turn away patients thought to have COVID-19, 83% of those same respondents employ protocols that could directly expose their staff and facilities to infected individuals during the screening process.
Raxia Contactless Check-In helps remove the risk of exposing staff and patients to COVID-19 during the check-in and screening process while still providing an excellent patient experience by:
- Asking screening questions via a patient's own mobile device at the time of appointment prior to entering the premises, eliminating physical contact with the intake staff and the facility
- Eliminating waiting rooms with support for queuing workflows
- Directing at-risk patients to the right care facility
- Automating patient intake and appointment reminders for greater efficiency
- Accepting contactless payments and keeping payment details on-file
Raxia Contactless Check-In is not only touch-free and safe but streamlined so more patients can be seen every day, reducing the impact of COVID-19 screening processes on day-to-day healthcare operations.
"You should know whether someone has COVID-19 symptoms before they have any direct interaction with staff or other patients. And you should ask these important questions at the time of appointment to ensure the accuracy, timeliness, and reliability of the information provided," said Andy Kuan, Raxia CEO.
Related Industry Updates
ZEISS and Kyoto University consolidate strategic partnership
Nov 07, 2019
UK scientists UK team tests coronavirus vaccine on mice
Feb 13, 2020
IV Equipment Market Share, Growth by Top Company, Application, Driver, Trends & Forecasts by 2027
Mar 26, 2021
Cytovation Announces Dosing of First Patient in its Phase I/II CICILIA Trial Investigating CyPep-1 in Patients with Solid Cancers
May 27, 2020
qFIBS Demonstrates Suitability for Nonalcoholic Steatohepatitis (NASH) Assessment in Clinical Trials and Patient Care with Full Quantification of All Crucial Histopathological Features
Nov 11, 2019
Quest Diagnostics Begins to Perform COVID-19 Antibody Testing
Apr 22, 2020
Huami partners with Nanshan Zhong's team to fight COVID-19 coronavirus in a joint laboratory
Apr 13, 2020